• Ovarian Cancer

    • About CVac™

    • Treatment

    • Clinical Trials

Announcements24 January 2013
Series of investor days in Australia in February

Prima BioMed Ltd (ASX: PRR; NASDAQ: PBMD; ISIN: US74154B2034) is pleased to announce that CEO Matthew Lehman will host a series of investor days in Australia in February, to provide an update on the Company’s activities.

Details of dates and venues

Perth                
Monday, 4th February
Parmelia Hilton Hotel, 14 Mill St, Perth
10.00am – 11.30am local time

Melbourne
Tuesday, 5th February
Westin Melbourne Hotel, 205 Collins St, Melbourne
10.30am – 12.00noon local time

Brisbane
Wednesday, 6th February
Hilton Brisbane Hotel, 190 Elizabeth St, Brisbane
10.00am – 11.30am local time

Sydney
Thursday, 7th February
Radisson Blu Hotel, 27 O’Connell St, Sydney
10.30am – 12.00noon local time

Shareholders and other interested parties are kindly requested to RSVP to enquiries@primabiomed.com.au and identify the city of attendance by Friday 1st February.

Article as pdf >>
ml>
distributed by